The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Strategies, design, and chemistry in siRNA delivery systems
Open accessAbstract
Emerging therapeutics that utilize RNA interference (RNAi) have the potential to treat broad classes of diseases due to their ability to reversibly silence target genes. In August 2018, the FDA approved the first siRNA therapeutic, called ONPATTRO™ (Patisiran), for the treatment of transthyretin-mediated amyloidosis. This was an important milestone for the field of siRNA delivery that opens the door for additional siRNA drugs. Currently, more than 20 small interfering RNA (siRNA)-based therapies are in clinical trials for a wide variety of diseases including cancers, genetic disorders, and viral infections. To maximize therapeutic benefits of siRNA-based drugs, a number of chemical strategies have been applied to address issues associated with efficacy, specificity, and safety. This review focuses on the chemical perspectives behind non-viral siRNA delivery systems, including siRNA synthesis, siRNA conjugates, and nanoparticle delivery using nucleotides, lipids, and polymers. Tracing and understanding the chemical development of strategies to make siRNAs into drugs is important to guide development of additional clinical candidates and enable prolonged success of siRNA therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Sequence-Selective Recognition of DNA by Strand Displacement with a Thymine-Substituted Polyamide
Nielsen, P. E., Egholm, M., Berg, R. H., & Buchardt, O. (1991) · Science · doi:10.1126/science.1962210 · Cited by 3,332
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Self-citationDesign and development of polymers for gene delivery
Pack, D. W., Hoffman, A. S., Pun, S., & Stayton, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1775 · Cited by 2,568
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Nonviral vectors for gene delivery
Mintzer, M. A., & Simanek, E. E. (2009) · Chemical Reviews · doi:10.1021/cr800409e · Cited by 2,366
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
Self-citationZamecnik, P. C., & Stephenson, M. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.280 · Cited by 1,792
Gilleron, J., Querbes, W., Zeigerer, A., Borodovsky, A., Marsico, G., Schubert, U., Manygoats, K., Seifert, S., Andree, C., Stöter, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2612 · Cited by 1,681
Lu, Y., Aimetti, A. A., Langer, R., & Gu, Z. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.75 · Cited by 1,421
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267
The promises and pitfalls of RNA-interference-based therapeutics
Castanotto, D., & Rossi, J. J. (2009) · Nature · doi:10.1038/nature07758 · Cited by 1,221
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H.-P., Maraganore, J., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,203
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
Lee, H., Lytton-Jean, A. K. R., Chen, Y., Love, K. T., Park, A. I., Karagiannis, E. D., Sehgal, A., Querbes, W., Zurenko, C. S., Jayaraman, M., et al. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.73 · Cited by 1,169
Self-citationA combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150
Self-citationCutler, J. I., Auyeung, E., & Mirkin, C. A. (2012) · Journal of the American Chemical Society · doi:10.1021/ja209351u · Cited by 1,119
Koshkin, A. A., Singh, S. K., Nielsen, P., Rajwanshi, V. K., Kumar, R., Meldgaard, M., Olsen, C. E., & Wengel, J. (1998) · Tetrahedron · doi:10.1016/s0040-4020(98)00094-5 · Cited by 1,047
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
Song, E., Zhu, P., Lee, S.-K., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1101 · Cited by 1,021
Seeman, N. C. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060308-102244 · Cited by 992
Davis, M. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900015y · Cited by 977
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1339 · Cited by 974
Safety and efficacy of RNAi therapy for transthyretin amyloidosis
Coelho, T., Adams, D., Silva, A., Lozeron, P., Hawkins, P. N., Mant, T., Perez, J., Chiesa, J., Warrington, S., Tranter, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208760 · Cited by 971
Lipid-like materials for low-dose, in vivo gene silencing
Love, K. T., Mahon, K. P., Levins, C. G., Whitehead, K. A., Querbes, W., Dorkin, J. R., Qin, J., Cantley, W., Qin, L. L., Racie, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910603106 · Cited by 969
Self-citationEfficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
Sahay, G., Querbes, W., Alabi, C., Eltoukhy, A., Sarkar, S., Zurenko, C., Karagiannis, E., Love, K., Chen, D., Zoncu, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2614 · Cited by 948
Self-citationRaal, F. J., Santos, R. D., Blom, D. J., Marais, A. D., Charng, M.-J., Cromwell, W. C., Lachmann, R. H., Gaudet, D., Tan, J. L., Chasan-Taber, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60284-x · Cited by 924
Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.
Stephenson, M. L., & Zamecnik, P. C. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.285 · Cited by 906
siRNA function in RNAi: A chemical modification analysis
CHIU, Y.-L., & RANA, T. M. (2003) · RNA · doi:10.1261/rna.5103703 · Cited by 860
Eckstein, F. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.002055 · Cited by 849
The emerging field of RNA nanotechnology
Guo, P. (2010) · Nature Nanotechnology · doi:10.1038/nnano.2010.231 · Cited by 718
Cutler, J. I., Auyeung, E., & Mirkin, C. A. (2020) · Spherical Nucleic Acids · doi:10.1201/9781003056676-5 · Cited by 676
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes
Rozema, D. B., Lewis, D. L., Wakefield, D. H., Wong, S. C., Klein, J. J., Roesch, P. L., Bertin, S. L., Reppen, T. W., Chu, Q., Blokhin, A. V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703778104 · Cited by 658
Advances in the delivery of RNA therapeutics: from concept to clinical reality
Kaczmarek, J. C., Kowalski, P. S., & Anderson, D. G. (2017) · Genome Medicine · doi:10.1186/s13073-017-0450-0 · Cited by 656
Self-citationMechanism of oligonucleotide release from cationic liposomes.
Zelphati, O., & Szoka, F. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11493 · Cited by 634
Maier, M. A., Jayaraman, M., Matsuda, S., Liu, J., Barros, S., Querbes, W., Tam, Y. K., Ansell, S. M., Kumar, V., Qin, J., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.124 · Cited by 625
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
Whitehead, K. A., Dorkin, J. R., Vegas, A. J., Chang, P. H., Veiseh, O., Matthews, J., Fenton, O. S., Zhang, Y., Olejnik, K. T., Yesilyurt, V., et al. (2014) · Nature Communications · doi:10.1038/ncomms5277 · Cited by 615
Self-citationAtrp in the design of functional materials for biomedical applications
Siegwart, D. J., Oh, J. K., & Matyjaszewski, K. (2012) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.08.001 · Cited by 613
Self-citationObika, S., Nanbu, D., Hari, Y., Morio, K.-I., In, Y., Ishida, T., & Imanishi, T. (1997) · Tetrahedron Letters · doi:10.1016/s0040-4039(97)10322-7 · Cited by 610
On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids
Hafez, I., Maurer, N., & Cullis, P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301506 · Cited by 601
Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma
Jensen, S. A., Day, E. S., Ko, C. H., Hurley, L. A., Luciano, J. P., Kouri, F. M., Merkel, T. J., Luthi, A. J., Patel, P. C., Cutler, J. I., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006839 · Cited by 592
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
Dahlman, J. E., Barnes, C., Khan, O. F., Thiriot, A., Jhunjunwala, S., Shaw, T. E., Xing, Y., Sager, H. B., Sahay, G., Speciner, L., et al. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.84 · Cited by 592
Self-citationDassie, J. P., Liu, X.-Y., Thomas, G. S., Whitaker, R. M., Thiel, K. W., Stockdale, K. R., Meyerholz, D. K., McCaffrey, A. P., McNamara, J. O., & Giangrande, P. H. (2009) · Nature Biotechnology · doi:10.1038/nbt.1560 · Cited by 589
RNA Interference in Vitro and in Vivo Using a Novel Chitosan/siRNA Nanoparticle System
Howard, K. A., Rahbek, U. L., Liu, X., Damgaard, C. K., Glud, S. Z., Andersen, M. Ø., Hovgaard, M. B., Schmitz, A., Nyengaard, J. R., Besenbacher, F., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.04.010 · Cited by 585
A combinatorial polymer library approach yields insight into nonviral gene delivery
Green, J. J., Langer, R., & Anderson, D. G. (2008) · Accounts of Chemical Research · doi:10.1021/ar7002336 · Cited by 579
Self-citationTherapeutic Antisense Oligonucleotides Are Coming of Age
Bennett, C. F. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-041217-010829 · Cited by 579
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids
Heyes, J., Palmer, L., Bremner, K., & MacLachlan, I. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.014 · Cited by 572
Herbert, B.-S., Pitts, A. E., Baker, S. I., Hamilton, S. E., Wright, W. E., Shay, J. W., & Corey, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14276 · Cited by 539
RNA Interference in Mammalian Cells by Chemically-Modified RNA
Braasch, D. A., Jensen, S., Liu, Y., Kaur, K., Arar, K., White, M. A., & Corey, D. R. (2003) · Biochemistry · doi:10.1021/bi0343774 · Cited by 531
Self-assembled RNA interference microsponges for efficient siRNA delivery
Lee, J. B., Hong, J., Bonner, D. K., Poon, Z., & Hammond, P. T. (2012) · Nature Materials · doi:10.1038/nmat3253 · Cited by 494
Alter, J., Lou, F., Rabinowitz, A., Yin, H., Rosenfeld, J., Wilton, S. D., Partridge, T. A., & Lu, Q. L. (2006) · Nature Medicine · doi:10.1038/nm1345 · Cited by 494
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Dong, Y., Love, K. T., Dorkin, J. R., Sirirungruang, S., Zhang, Y., Chen, D., Bogorad, R. L., Yin, H., Chen, Y., Vegas, A. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322937111 · Cited by 488
Self-citationOishi, M., Nagasaki, Y., Itaka, K., Nishiyama, N., & Kataoka, K. (2005) · Journal of the American Chemical Society · doi:10.1021/ja044941d · Cited by 476
Silencing disease genes in the laboratory and the clinic
Watts, J. K., & Corey, D. R. (2012) · The Journal of Pathology · doi:10.1002/path.2993 · Cited by 470
Lavertu, M., Méthot, S., Tran-Khanh, N., & Buschmann, M. D. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.04.029 · Cited by 448
Lipid‐based nanotherapeutics for siRNA delivery
Schroeder, A., Levins, C. G., Cortez, C., Langer, R., & Anderson, D. G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02189.x · Cited by 447
Self-citationCurrent progress of siRNA/shRNA therapeutics in clinical trials
Burnett, J. C., Rossi, J. J., & Tiemann, K. (2011) · Biotechnology Journal · doi:10.1002/biot.201100054 · Cited by 444
Woodrow, K. A., Cu, Y., Booth, C. J., Saucier-Sawyer, J. K., Wood, M. J., & Mark Saltzman, W. (2009) · Nature Materials · doi:10.1038/nmat2444 · Cited by 438
Shu, D., Shu, Y., Haque, F., Abdelmawla, S., & Guo, P. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.105 · Cited by 435
Chemically modified siRNA: tools and applications
Watts, J. K., Deleavey, G. F., & Damha, M. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.05.007 · Cited by 431
Clinical experiences with systemically administered siRNA-based therapeutics in cancer
Zuckerman, J. E., & Davis, M. E. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4685 · Cited by 424
Lynn, D. M., Anderson, D. G., Putnam, D., & Langer, R. (2001) · Journal of the American Chemical Society · doi:10.1021/ja016288p · Cited by 393
Self-citationConjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells
Muratovska, A., & Eccles, M. R. (2004) · FEBS Letters · doi:10.1016/s0014-5793(03)01505-9 · Cited by 390
Visualizing a Correlation between siRNA Localization, Cellular Uptake, and RNAi in Living Cells
Chiu, Y.-L., Ali, A., Chu, C.-Y., Cao, H., & Rana, T. M. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.06.006 · Cited by 381
Bramsen, J. B., Laursen, M. B., Nielsen, A. F., Hansen, T. B., Bus, C., Langkjær, N., Babu, B. R., Højland, T., Abramov, M., Van Aerschot, A., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp106 · Cited by 369
A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Fisch, G., Dames, S., Löffler, K., Fechtner, M., Arnold, W., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302777 · Cited by 368
Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., & Park, T. G. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.008 · Cited by 362
Advancement of the emerging field of RNA nanotechnology
Jasinski, D., Haque, F., Binzel, D. W., & Guo, P. (2017) · ACS Nano · doi:10.1021/acsnano.6b05737 · Cited by 352
PAMAM dendrimers for efficient siRNA delivery and potent gene silencing
Zhou, J., Wu, J., Hafdi, N., Behr, J.-P., Erbacher, P., & Peng, L. (2006) · Chemical Communications · doi:10.1039/b601381c · Cited by 342
Xu, X., Xie, K., Zhang, X.-Q., Pridgen, E. M., Park, G. Y., Cui, D. S., Shi, J., Wu, J., Kantoff, P. W., Lippard, S. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303958110 · Cited by 340
siRNA Conjugate Delivery Systems
Jeong, J. H., Mok, H., Oh, Y.-K., & Park, T. G. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800278e · Cited by 338
Polymer–Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs
Kaczmarek, J. C., Patel, A. K., Kauffman, K. J., Fenton, O. S., Webber, M. J., Heartlein, M. W., DeRosa, F., & Anderson, D. G. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201608450 · Cited by 334
Self-citationTherapeutic plasmid DNA versus siRNA delivery: Common and different tasks for synthetic carriers
Scholz, C., & Wagner, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.014 · Cited by 333
Matsumoto, S., Christie, R. J., Nishiyama, N., Miyata, K., Ishii, A., Oba, M., Koyama, H., Yamasaki, Y., & Kataoka, K. (2009) · Biomacromolecules · doi:10.1021/bm800985e · Cited by 327
Sehgal, A., Barros, S., Ivanciu, L., Cooley, B., Qin, J., Racie, T., Hettinger, J., Carioto, M., Jiang, Y., Brodsky, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3847 · Cited by 306
Letsinger, R. L., Zhang, G. R., Sun, D. K., Ikeuchi, T., & Sarin, P. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6553 · Cited by 304
Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides
Juliano, R., Bauman, J., Kang, H., & Ming, X. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900093r · Cited by 304
Mutant KRAS is a druggable target for pancreatic cancer
Zorde Khvalevsky, E., Gabai, R., Rachmut, I. H., Horwitz, E., Brunschwig, Z., Orbach, A., Shemi, A., Golan, T., Domb, A. J., Yavin, E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314307110 · Cited by 295
Nelson, C. E., Kintzing, J. R., Hanna, A., Shannon, J. M., Gupta, M. K., & Duvall, C. L. (2013) · ACS Nano · doi:10.1021/nn403325f · Cited by 293
Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection
Wooddell, C. I., Rozema, D. B., Hossbach, M., John, M., Hamilton, H. L., Chu, Q., Hegge, J. O., Klein, J. J., Wakefield, D. H., Oropeza, C. E., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.31 · Cited by 293
In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles
Su, X., Fricke, J., Kavanagh, D. G., & Irvine, D. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100390w · Cited by 287
RNA interference using boranophosphate siRNAs: structure-activity relationships
Hall, A. H. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh936 · Cited by 285
Conde, J., Oliva, N., Atilano, M., Song, H. S., & Artzi, N. (2016) · Nature Materials · doi:10.1038/nmat4497 · Cited by 283
Phosphorothioation of DNA in bacteria by dnd genes
Wang, L., Chen, S., Xu, T., Taghizadeh, K., Wishnok, J. S., Zhou, X., You, D., Deng, Z., & Dedon, P. C. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.39 · Cited by 274
The Headgroup Evolution of Cationic Lipids for Gene Delivery
Zhi, D., Zhang, S., Cui, S., Zhao, Y., Wang, Y., & Zhao, D. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300381s · Cited by 271
Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins
McNaughton, B. R., Cronican, J. J., Thompson, D. B., & Liu, D. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807883106 · Cited by 266
Single-Stranded siRNAs Activate RNAi in Animals
Lima, W. F., Prakash, T. P., Murray, H. M., Kinberger, G. A., Li, W., Chappell, A. E., Li, C. S., Murray, S. F., Gaus, H., Seth, P. P., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.014 · Cited by 256
Stable RNA nanoparticles as potential new generation drugs for cancer therapy
Shu, Y., Pi, F., Sharma, A., Rajabi, M., Haque, F., Shu, D., Leggas, M., Evers, B. M., & Guo, P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.006 · Cited by 244
Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy
Yang, X.-Z., Dou, S., Sun, T.-M., Mao, C.-Q., Wang, H.-X., & Wang, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.035 · Cited by 242
Small RNA combination therapy for lung cancer
Xue, W., Dahlman, J. E., Tammela, T., Khan, O. F., Sood, S., Dave, A., Cai, W., Chirino, L. M., Yang, G. R., Bronson, R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412686111 · Cited by 242
Self-citationYu, H., Zou, Y., Wang, Y., Huang, X., Huang, G., Sumer, B. D., Boothman, D. A., & Gao, J. (2011) · ACS Nano · doi:10.1021/nn203503h · Cited by 238
RNA Helicase A Interacts with RISC in Human Cells and Functions in RISC Loading
Robb, G. B., & Rana, T. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.016 · Cited by 225
Matsuda, S., Keiser, K., Nair, J. K., Charisse, K., Manoharan, R. M., Kretschmer, P., Peng, C. G., V. Kel’in, A., Kandasamy, P., Willoughby, J. L. S., et al. (2015) · ACS Chemical Biology · doi:10.1021/cb501028c · Cited by 221
Surface-Modified and Internally Cationic Polyamidoamine Dendrimers for Efficient siRNA Delivery
Patil, M. L., Zhang, M., Betigeri, S., Taratula, O., He, H., & Minko, T. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8000722 · Cited by 213
RNAi modulation of placental sFLT1 for the treatment of preeclampsia
Turanov, A. A., Lo, A., Hassler, M. R., Makris, A., Ashar-Patel, A., Alterman, J. F., Coles, A. H., Haraszti, R. A., Roux, L., Godinho, B. M. D. C., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4297 · Cited by 213
Abrams, M. T., Koser, M. L., Seitzer, J., Williams, S. C., DiPietro, M. A., Wang, W., Shaw, A. W., Mao, X., Jadhav, V., Davide, J. P., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.208 · Cited by 209
Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery
Siegwart, D. J., Whitehead, K. A., Nuhn, L., Sahay, G., Cheng, H., Jiang, S., Ma, M., Lytton-Jean, A., Vegas, A., Fenton, P., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106379108 · Cited by 198
Self-citationSolid‐Phase Synthesis of Sequence‐Defined T‐, i‐, and U‐Shape Polymers for pDNA and siRNA Delivery
Schaffert, D., Troiber, C., Salcher, E. E., Fröhlich, T., Martin, I., Badgujar, N., Dohmen, C., Edinger, D., Kläger, R., Maiwald, G., et al. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201102165 · Cited by 196
Shi, J., Xiao, Z., Votruba, A. R., Vilos, C., & Farokhzad, O. C. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101554 · Cited by 196
Wang, Y., Xu, Z., Guo, S., Zhang, L., Sharma, A., Robertson, G. P., & Huang, L. (2013) · Molecular Therapy · doi:10.1038/mt.2013.135 · Cited by 191
Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery
Alabi, C. A., Love, K. T., Sahay, G., Yin, H., Luly, K. M., Langer, R., & Anderson, D. G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306529110 · Cited by 188
Self-citationTargeted Delivery of PLK1-siRNA by ScFv Suppresses Her2 + Breast Cancer Growth and Metastasis
Yao, Y.-D., Sun, T.-M., Huang, S.-Y., Dou, S., Lin, L., Chen, J.-N., Ruan, J.-B., Mao, C.-Q., Yu, F.-Y., Zeng, M.-S., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003601 · Cited by 188
Delivery of Multiple siRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate Cancer
Hasan, W., Chu, K., Gullapalli, A., Dunn, S. S., Enlow, E. M., Luft, J. C., Tian, S., Napier, M. E., Pohlhaus, P. D., Rolland, J. P., et al. (2012) · Nano Letters · doi:10.1021/nl2035354 · Cited by 187
Zhou, K., Nguyen, L. H., Miller, J. B., Yan, Y., Kos, P., Xiong, H., Li, L., Hao, J., Minnig, J. T., Zhu, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520756113 · Cited by 183
Self-citationKozielski, K. L., Tzeng, S. Y., Hurtado De Mendoza, B. A., & Green, J. J. (2014) · ACS Nano · doi:10.1021/nn500704t · Cited by 180
Lee, J. H., Lim, Y.-B., Choi, J. S., Lee, Y., Kim, T.-I., Kim, H. J., Yoon, J. K., Kim, K., & Park, J.-S. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034095g · Cited by 179
Endosomolysis by Masking of a Membrane-Active Agent (EMMA) for Cytoplasmic Release of Macromolecules
Rozema, D. B., Ekena, K., Lewis, D. L., Loomis, A. G., & Wolff, J. A. (2003) · Bioconjugate Chemistry · doi:10.1021/bc0255945 · Cited by 161
Single-Step Assembly of Cationic Lipid–Polymer Hybrid Nanoparticles for Systemic Delivery of siRNA
Yang, X.-Z., Dou, S., Wang, Y.-C., Long, H.-Y., Xiong, M.-H., Mao, C.-Q., Yao, Y.-D., & Wang, J. (2012) · ACS Nano · doi:10.1021/nn300500u · Cited by 159
Alnylam launches era of RNAi drugs
Garber, K. (2018) · Nature Biotechnology · doi:10.1038/nbt0918-777 · Cited by 157
Langkjær, N., Pasternak, A., & Wengel, J. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.06.045 · Cited by 150
Kubiak, K., Sochacka, E., Kaźmierczak-Barańska, J., Maszewska, M., Janicka, M., Nowak, G., & Nawrot, B. (2007) · RNA · doi:10.1261/rna.538907 · Cited by 149
Wu, S. Y., Yang, X., Gharpure, K. M., Hatakeyama, H., Egli, M., McGuire, M. H., Nagaraja, A. S., Miyake, T. M., Rupaimoole, R., Pecot, C. V., et al. (2014) · Nature Communications · doi:10.1038/ncomms4459 · Cited by 146
Desigaux, L., Sainlos, M., Lambert, O., Chèvre, R., Letrou-Bonneval, E., Vigneron, J., Lehn, P., Lehn, J., & Pitard, B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707431104 · Cited by 146
Nucleoside and Oligonucleoside Boranophosphates: Chemistry and Properties
Li, P., Sergueeva, Z. A., Dobrikov, M. I., & Shaw, B. R. (2007) · Chemical Reviews · doi:10.1021/cr050009p · Cited by 144
Liu, X., Rocchi, P., Qu, F., Zheng, S., Liang, Z., Gleave, M. E., Iovanna, J., & Peng, L. (2009) · ChemMedChem · doi:10.1002/cmdc.200900076 · Cited by 140
Kwok, A., & Hart, S. L. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.07.005 · Cited by 139
Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells
Novobrantseva, T. I., Borodovsky, A., Wong, J., Klebanov, B., Zafari, M. R., Yucius, K., Querbes, W., Ge, P., Ruda, V. M., Milstein, S., et al. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2011.3 · Cited by 139
Self-citationPolyion complex stability and gene silencing efficiency with a siRNA-grafted polymer delivery system
Takemoto, H., Ishii, A., Miyata, K., Nakanishi, M., Oba, M., Ishii, T., Yamasaki, Y., Nishiyama, N., & Kataoka, K. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.015 · Cited by 123
Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivo
Laursen, M. B., Pakula, M. M., Gao, S., Fluiter, K., Mook, O. R. F., Baas, F., Langkjær, N., Wengel, S. L., Wengel, J., Kjems, J., et al. (2010) · Molecular BioSystems · doi:10.1039/b918869j · Cited by 121
Stanzl, E. G., Cooley, C. B., Simon, J., Kiesewetter, M. K., Edward, J. A., Hickerson, R. P., Kaspar, R. L., Hedrick, J. L., Waymouth, R. M., & Wender, P. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211361109 · Cited by 120
Novel Fmoc-Polyamino Acids for Solid-Phase Synthesis of Defined Polyamidoamines
Schaffert, D., Badgujar, N. S., & Wagner, E. (2011) · Organic Letters · doi:10.1021/ol200381z · Cited by 119
An additional sugar component of ribonucleic acids
Smith, J., & Dunn, D. B. (1959) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(59)90045-9 · Cited by 115
Stirchak, E. P., Summerton, J. E., & Weller, D. D. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6129 · Cited by 115
Aptamer-siRNA Chimeras: Discovery, Progress, and Future Prospects
Kruspe, S., & Giangrande, P. H. (2017) · Biomedicines · doi:10.3390/biomedicines5030045 · Cited by 106
Hao, J., Kós, P., Zhou, K., Miller, J. B., Xue, L., Yan, Y., Xiong, H., Elkassih, S. A., & Siegwart, D. J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b03429 · Cited by 105
Self-citationWong, S. C., Klein, J. J., Hamilton, H., Chu, Q., Frey, C. L., Trubetskoy, V. S., Hegge, J., Wakefield, D. H., Rozema, D. B., & Lewis, D. L. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0389 · Cited by 101
Prakash, T. P., Lima, W. F., Murray, H. M., Li, W., Kinberger, G. A., Chappell, A. E., Gaus, H. J., Seth, P. P., Bhat, B., Crooke, S. T., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv162 · Cited by 99
Khan, O. F., Zaia, E. W., Yin, H., Bogorad, R. L., Pelet, J. M., Webber, M. J., Zhuang, I., Dahlman, J. E., Langer, R., & Anderson, D. G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201408221 · Cited by 99
Self-citationSelf-assembled siRNA–PLGA conjugate micelles for gene silencing
Hyeon, L. S., Mok, H., Lee, Y., & Park, T. G. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.12.007 · Cited by 97
Christie, R. J., Miyata, K., Matsumoto, Y., Nomoto, T., Menasco, D., Lai, T. C., Pennisi, M., Osada, K., Fukushima, S., Nishiyama, N., et al. (2011) · Biomacromolecules · doi:10.1021/bm2006714 · Cited by 94
Philipp, A. B., Zhao, X. B., Tarcha, P. J., Wagner, E., & Zintchenko, A. (2009) · Bioconjugate Chemistry · doi:10.1021/bc9001536 · Cited by 87
Gene Silencing Activity of siRNAs with a Ribo-difluorotoluyl Nucleotide
Xia, J. L., Noronha, A. M., Toudjarska, I., Li, F., Akinc, A., Braich, R. S., Frank-Kamenetsky, M. D., Rajeev, K. G., Egli, M., & Manoharan, M. (2006) · ACS Chemical Biology · doi:10.1021/cb600063p · Cited by 85
A bioreducible linear poly(β-amino ester) for siRNA delivery
Kozielski, K., Tzeng, S. Y., & Green, J. J. (2013) · Chemical Communications · doi:10.1039/c3cc40718g · Cited by 78
Cesarone, G., Edupuganti, O. P., Chen, C.-P., & Wickstrom, E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070135v · Cited by 77
Preparation of Cationic Nanogels for Nucleic Acid Delivery
Averick, S. E., Paredes, E., Irastorza, A., Shrivats, A. R., Srinivasan, A., Siegwart, D. J., Magenau, A. J. D., Cho, H. Y., Hsu, E., Averick, A., et al. (2012) · Biomacromolecules · doi:10.1021/bm301166s · Cited by 77
Self-citationRNA interference: a chemist's perspective
Gaynor, J. W., Campbell, B. J., & Cosstick, R. (2010) · Chemical Society Reviews · doi:10.1039/b920362c · Cited by 76
RAFT-synthesized copolymers and conjugates designed for therapeutic delivery of siRNA
Smith, D., Holley, A. C., & McCormick, C. L. (2011) · Polymer Chemistry · doi:10.1039/c1py00038a · Cited by 71
Single siRNA Nanocapsules for Enhanced RNAi Delivery
Yan, M., Liang, M., Wen, J., Liu, Y., Lu, Y., & Chen, I. S. Y. (2012) · Journal of the American Chemical Society · doi:10.1021/ja304649a · Cited by 69
The Direct Preparation of 2'-O-Methyladenosine from Adenosine1
Broom, A. D., & Robins, R. K. (1965) · Journal of the American Chemical Society · doi:10.1021/ja01083a045 · Cited by 68
He, W., Bennett, M. J., Luistro, L. L., Carvajal, D. M., Nevins, T. D., Smith, M., Tyagi, G., Cai, J. J., Wei, X. L., Lin, T.-A., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.210 · Cited by 65
A Cell-penetrating Helical Polymer For siRNA Delivery to Mammalian Cells
Gabrielson, N. P., Lu, H., Yin, L., Kim, K. H., & Cheng, J. (2012) · Molecular Therapy · doi:10.1038/mt.2012.78 · Cited by 62
Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1
Zhou, J., Lazar, D. C., Li, H., Xia, X., Satheesan, S., Charlins, P., O’Meally, D., Akkina, R., Saayman, S. M., Weinberg, M. S., et al. (2018) · Theranostics · doi:10.7150/thno.23085 · Cited by 62
Parmar, R. G., Brown, C. R., Matsuda, S., Willoughby, J. L. S., Theile, C. S., Charissé, K., Foster, D. J., Zlatev, I., Jadhav, V., Maier, M. A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01147 · Cited by 58
Alkane-modified short polyethyleneimine for siRNA delivery
Schroeder, A., Dahlman, J. E., Sahay, G., Love, K. T., Jiang, S., Eltoukhy, A. A., Levins, C. G., Wang, Y., & Anderson, D. G. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.030 · Cited by 50
Self-citationAn Amino Acid-based Amphoteric Liposomal Delivery System for Systemic Administration of siRNA
Adami, R. C., Seth, S., Harvie, P., Johns, R. E., Fam, R., Fosnaugh, K. L., Zhu, T., Farber, K., McCutcheon, M., Goodman, T. T., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.56 · Cited by 49
Biological effects of hexitol and altritol-modified siRNAs targeting B-Raf
FISHER, M. S., Abramov, M., Aerschot, A. A. V., Rozenski, J., Dixit, V., Juliano, R. L., & Herdewijn, P. A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.01.030 · Cited by 45
Miller, J. B., & Siegwart, D. J. (2018) · Nano Research · doi:10.1007/s12274-018-2099-4 · Cited by 44
Self-citationControlling miRNA-like off-target effects of an siRNA with nucleobase modifications
Suter, S. R., Ball‐Jones, A. A., Mumbleau, M. M., Valenzuela, R., Ibarra‐Soza, J. M., Owens, H., Fisher, A. J., & Beal, P. A. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob02654d · Cited by 42
Hanessian, S., Schroeder, B. R., Giacometti, R. D., Merner, B. L., Østergaard, M. E., Swayze, E. E., & Seth, P. P. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203680 · Cited by 35
Barrett, S. E., Burke, R. S., Abrams, M. T., Bason, C., Busuek, M., Carlini, E. J., Carr, B., Crocker, L. S., Fan, H., Garbaccio, R. M., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.028 · Cited by 31
Development of siRNA-probes for studying intracellular trafficking of siRNA nanoparticles
Alabi, C. A., Sahay, G., Langer, R., & Anderson, D. G. (2012) · Integrative Biology · doi:10.1039/c2ib20155k · Cited by 29
Self-citationParmar, R. G., Poslusney, M., Busuek, M., Williams, J. M., Garbaccio, R. M., Leander, K. R., Walsh, E. S., Howell, B. J., Sepp‐Lorenzino, L., Riley, S., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc400527e · Cited by 23
Guidry, E. N., Farand, J., Soheili, A., Parish, C. A., Kevin, N. J., Pipik, B., Calati, K., Ikemoto, N., Waldman, J. H., Latham, A. H., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc400442p · Cited by 19
Salinas, J. C., Yu, J., Østergaard, M. E., Seth, P. P., & Hanessian, S. (2018) · Organic Letters · doi:10.1021/acs.orglett.8b02233 · Cited by 15
Intercalation-mediated nucleic acid nanoparticles for siRNA delivery
Zhou, K., Kós, P., Yan, Y., Xiong, H., Min, Y.-L., Kinghorn, K., Minnig, J. T., Miller, J. B., & Siegwart, D. J. (2016) · Chemical Communications · doi:10.1039/c6cc06024b · Cited by 13
Self-citationBrissault, B., Leborgne, C., Scherman, D., et al. (2011) · Macromolecular Bioscience · doi:10.1002/mabi.201000404 · Cited by 10
Cited by
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Endoplasmic reticulum stress: molecular mechanism and therapeutic targets
Chen, X., Shi, C., He, M., Xiong, S., & Xia, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01570-w · Cited by 1,007
Dilliard, S. A., & Siegwart, D. J. (2023) · Nature Reviews Materials · doi:10.1038/s41578-022-00529-7 · Cited by 671
Self-citationLipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics
Kulkarni, J. A., Witzigmann, D., Chen, S., Cullis, P. R., & van der Meel, R. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00368 · Cited by 527
Therapeutic siRNA: State-of-the-Art and Future Perspectives
Friedrich, M., & Aigner, A. (2022) · BioDrugs · doi:10.1007/s40259-022-00549-3 · Cited by 396
Metadata
- Authors
- Dong, Y., Siegwart, D. J., & Anderson, D. G.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 144
- Pages
- 133-147
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2945507495
- Cited by
- 572
- References
- 159
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.